Ropes & Gray has advised leading global private markets firm, Partners Group, acting on behalf of its clients, on its investment in GHO Capital Partners’ portfolio company, Sterling Pharma Solutions (“Sterling”), a global Contract Development and Manufacturing Organisation (“CDMO”).
Sterling provides a full range of CDMO services across the lifecycle of new, high-value active pharmaceutical ingredients (“APIs”) and is an industry leader in the early-stage development of antibody drug conjugates (“ADCs”), a fast-growing class of cancer treatments. It benefits from a diversified blue-chip customer base and is a supply chain partner for the majority of the largest pharmaceutical companies.
Partners Group acquires a significant minority stake, bringing a wealth of international healthcare expertise to the shareholder group and helping drive future value creation.
The new investment will support Sterling as it accelerates its growth plans through the expansion of production capacity across Europe and the US. The funding also enables it to pursue further strategic acquisitions to further expand its capabilities and continue to advance its strong commitment to ESG initiatives.
